The Kenyan government, through the Kenya Institute of Primate Research (KIPR), has accelerated plans to produce the first locally manufactured snake antivenom in East Africa. The move follows a surge in medically significant snakebite cases and a persistent shortage of effective, affordable treatment options across the country’s high-burden regions.
Rising Human-Wildlife Conflict
The urgency of the project was recently highlighted by a series of high-profile encounters in snakebite hotspots. In Kitui County’s Mwingi North, a 26-year-old man, Bernard Kyalo, survived a cobra attack while relieving himself in an outdoor area. Kyalo, who is currently recovering from injuries to his genitals, has formally requested government compensation, highlighting the increasing interaction between humans and venomous species in hot, dry environments.
This incident follows a wider regional trend of escalating snakebite fatalities. Experts estimate that between 15 and 25 people die daily from snakebites in Kenya, with at least 30,000 cases recorded annually. In addition to the fatalities, approximately 4,000 survivors suffer permanent physical disabilities and psychological trauma, such as post-traumatic stress disorder (PTSD).
The Scientific Challenge of Antivenom Efficacy
Currently, Kenya relies heavily on imported antivenoms from India, South America, and Europe. However, medical experts have flagged significant efficacy issues due to “geographic variation” in snake venom. Dr. George Oluoch, Head of the Kenya Snakebite Research & Intervention Centre (K-SRIC), explained that venom from a specific species—such as a Puff Adder—can differ significantly in chemical composition between regions, such as Kilifi and Baringo.
“By using venom extracted from locally occurring snake species, we can significantly improve the effectiveness of antivenoms in treating snakebites within our region,” Dr. Oluoch stated. The local production initiative aims to create “polyvalent” antivenoms—vials that can treat bites from multiple species—tailored specifically to the 13 venomous snakes of major medical significance in Kenya.
More Read
Mapping Kenya’s Most Dangerous Species
Kenya is home to several highly potent neurotoxic and cytotoxic snakes. The KIPR has identified 13 species that require immediate medical attention if an encounter leads to a bite:
- Neurotoxic (Nervous System): The Black Mamba and Eastern Green Mamba. These species can cause rapid paralysis and are often fatal within minutes without intervention.
- Cytotoxic (Tissue Damage): The Puff Adder and various Spitting Cobras (Red, Large Brown, and Black-Necked). These bites cause severe swelling, necrosis (tissue death), and often lead to limb amputations.
- Haematotoxic (Blood Clotting): The Boomslang and the Saw-Scaled Viper (Echis), which cause internal and external bleeding.
Government Intervention and Future Outlook
The government has officially integrated snakebite envenoming into the National Master Plan for Neglected Tropical Diseases (NTDs). As part of this strategy, KIPR is leading a multi-disciplinary effort to map snake populations and establish a National Antivenom Quality Control Laboratory.
A landmark community survey covering 13 million people recently revealed that snakebite incidence is much higher than previously reported in official health facility databases. Turkana County was identified as the region with the highest burden, with over 412 cases per 100,000 people.
More Read
The first batch of Kenyan-produced antivenom vials is expected to be released for clinical use within the next two years. The Ministry of Health believes this will not only lower the cost of treatment but also ensure a more reliable supply chain for rural health facilities, which are often the first point of contact for victims in remote areas.
Expected Developments
Moving forward, the government plans to strengthen the capacity of community health promoters to educate the public on coexistence and first aid. As climate change continues to drive snakes closer to human settlements due to extreme flooding and droughts, these community-based interventions are expected to play a vital role in reducing the national mortality rate.
